Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 22Neoplasm Metastasis 17Lung Neoplasms 10Carcinoma, Hepatocellular 10Prostatic Neoplasms 9Melanoma 9Carcinoma, Renal Cell 9Carcinoma, Non-Small-Cell Lung 9Liver Neoplasms 8Sarcoma 7Kidney Neoplasms 7Pain 6Colorectal Neoplasms 5Esophageal Neoplasms 4Triple Negative Breast Neoplasms 3Thyroid Neoplasms 3Small Cell Lung Carcinoma 3Osteosarcoma 3Neoplasms 3Keratosis, Actinic 3Cholangiocarcinoma 3Carcinoma, Ductal, Breast 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Tongue Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Desmoid Tumors 2Colonic Neoplasms 2Carcinoma, Transitional Cell 2

Interventions

Gemcitabine 157Cisplatin 116pembrolizumab 80Nivolumab 42Carboplatin 42Paclitaxel 41Mitomycin 41Cystectomy 40Docetaxel 38atezolizumab 33Magnetic Resonance Spectroscopy 31durvalumab 30Radiotherapy 29BCG Vaccine 26avelumab 24Specimen Handling 24Doxorubicin 23enfortumab vedotin 22Fluorouracil 20Cystoscopy 20Methotrexate 17Vinblastine 16Standard of Care 15Filgrastim 14Transurethral Resection of Bladder 13Sunitinib 13Ipilimumab 13vinflunine 125-aminolevulinic acid hexyl ester 12tremelimumab 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Urinary Bladder Neoplasms × Cryosurgery × Clear all
NCT04701918 2026-01-22

Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma

Massachusetts General Hospital

Phase 2 Completed
9 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT02760953 2017-10-19

TURBt With Adjuvant Cryoablation to Treat Bladder Cancer

Huashan Hospital

Phase NA Unknown
150 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡